Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The result indicates that the overall pathway is feasible but acetate kinase (AckA) is the limiting step (Figure 4)
Injection burden 2-3 injections per day on TB-500 days Best for Dose flexibility, injury-focused work Cycle driver GHK-Cu cycling typically sets the cycle length BPC-157 Loading 250-500 mcg/day (weeks 1-4) Frequency Daily Maintenance 250 mcg/day (weeks 5-8+) Route SubQ near injury or oral TB-500 Loading 2.5-5 mg per injection (weeks 1-4) Frequency 2x/week Maintenance 2 mg per injection (weeks 5-8+) Route SubQ systemic GHK-Cu Loading 1-2 mg/day (weeks 1-4) Frequency Daily Maintenance 1 mg/day (weeks 5-8+) Route SubQ Weekly Schedule Example Monday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Tuesday BPC-157 500 mcg + GHK-Cu 1-2 mg Wednesday BPC-157 500 mcg + GHK-Cu 1-2 mg Thursday BPC-157 500 mcg + TB-500 2.5 mg + GHK-Cu 1-2 mg Friday BPC-157 500 mcg + GHK-Cu 1-2 mg Saturday BPC-157 500 mcg + GHK-Cu 1-2 mg Sunday BPC-157 500 mcg + GHK-Cu 1-2 mg Use a separate syringe for each compound
(States that niacin should be used in pregnancy only if the benefit outweighs the risk
Step-by-step protocols from Canadian specialists
Some combination
Research Findings The research foundation for Epithalon is substantial, though much of this work has been conducted in Russia and published primarily in Russian or Eastern European journals, with less representation in mainstream Western scientific literature
US$ 27.99
US$ 23.01
US$ 27.42
